Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 42, Pages 35496-35505Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M112.400697
Keywords
-
Categories
Funding
- U. S. Public Health Service Grant from the National Cancer Institute, National Institutes of Health [R01CA149253]
Ask authors/readers for more resources
Lysine acetylation regulates protein stability and function. p300 is a component of the HIF-1 transcriptional complex and positively regulates the transactivation of HIF-1. Here, we show a novel molecular mechanism by which p300 facilitates HIF-1 activity. p300 increases HIF-1 alpha (HIF1 alpha) protein acetylation and stability. The regulation can be opposed by HDAC1, but not by HDAC3, and is abrogated by disrupting HIF1 alpha-p300 interaction. Mechanistically, p300 specifically acetylates HIF1 alpha at Lys-709, which increases the protein stability and decreases polyubiquitination in both normoxia and hypoxia. Compared with the wild-type protein, a HIF1 alpha K709A mutant protein is more stable, less polyubiquitinated, and less dependent on p300. Overexpression of the HIF1 alpha wild-type or K709A mutant in cancer cells lacking the endogenous HIF1 alpha shows that the K709A mutant is transcriptionally more active toward the HIF-1 reporter and some endogenous target genes. Cancer cells containing the K709A mutant are less sensitive to hypoxia-induced growth arrest than the cells containing the HIF1 alpha wildtype. Taken together, these data demonstrate a novel biological consequence upon HIF1 alpha-p300 interaction, in which HIF1 alpha can be stabilized by p300 via Lys-709 acetylation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available